Hanmi Pharm’s side effect incident causes issues to devaluate efforts in new drug dev

While some raise voices to derogate the accumulated performance of the pharmaceutical industry based on the case of Hanmi Pharm having side effects on its antibody, some said the Hanmi Pharm’s case should not be a reason to derogate the overall effort of the industry in developing new drugs.

It is a problem to unconditionally have high expectations in new drug development, but depressing the i...